Medicine News and Research

RSS

Patient navigation services help vulnerable patients get timely cancer care

Researchers at Boston Medical Center (BMC) have shown that patient navigation services help decrease the time to diagnosis for female patients who have received an abnormal result from a breast or cervical cancer screening.

10 Oct 2012

Researchers discover mechanism by which magnesium reduces cytokine production

Magnesium sulfate is given to many pregnant women to treat preterm labor and preeclampsia and was recently shown to prevent cerebral palsy; however little is known about how it works. Researchers at Case Western Reserve University School of Medicine recently discovered the mechanism by which magnesium reduces the production of cytokines.

10 Oct 2012

ProteoWizard Toolkit interprets multi-platform mass spectrometry data

The world's leading mass spectrometer manufacturers have agreed to license technology that enabled University of Southern California (USC) researchers to develop software that, for the first time, allows scientists to easily use and share research data collected across proprietary platforms.

From Thermo Fisher Scientific Inc. 10 Oct 2012

Vitamin C actively protects against osteoporosis

Researchers at Mount Sinai School of Medicine have shown for the first time in an animal model that vitamin C actively protects against osteoporosis, a disease affecting large numbers of elderly women and men in which bones become brittle and can fracture. The findings are published in the October 8 online edition of PLoS ONE.

10 Oct 2012

Biomet first quarter net sales increase 6% to $707.4 million

Biomet, Inc. announced today financial results for its first fiscal quarter ended August 31, 2012.

10 Oct 2012

Viewpoints: David Brooks' praise for Ryan plan; Medicaid overlooked in presidential debate; Romney proposal effective for pre-existing conditions

In Thursday night's debate, Vice President Joe Biden will almost certainly go after Representative Paul Ryan's Medicare plan. And why shouldn't he? It's unpopular. But I'd like to make a case for that plan. It's the best thing the Romney-Ryan campaign has going for it.

10 Oct 2012

Grp94 chaperone protein can interfere with clearance of myocilin from cells

The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells.

10 Oct 2012

CT technique could improve COPD classification

The parametric response map technique can be used in chronic obstructive pulmonary disease to distinguish between disease subtypes, say US researchers.

9 Oct 2012

Point-of-care testing speeds patients through ED

Using point-of-care testing, instead of sending samples to a central laboratory, reduces the length of time that patients stay in the emergency department, shows a randomized trial.

9 Oct 2012

Two novel GFR equations predict kidney function in elderly

Researchers report that two “new” equations may accurately measure kidney function in elderly individuals with nonsevere kidney disease.

9 Oct 2012

Early communication strategies improve end of liver transplant patients’ lives

A multidisciplinary communication intervention involving physicians and family members of liver transplant patients treated in surgical intensive care units can improve end-of-life care, show study results.

9 Oct 2012

Isolated fetal echogenic bowel ‘may be benign’

Results of a Dutch study show that the majority of fetuses with fetal echogenic bowel carry a good prognosis.

9 Oct 2012

MRI method ‘cuts breast cancer false‑positives’

Assessing apparent diffusion coefficients during dynamic contrast-enhanced magnetic resonance imaging may reduce the number of avoidable false‑positive breast cancer results and unnecessary biopsies, show findings published in Radiology.

9 Oct 2012

Johns Hopkins joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that Johns Hopkins University School of Medicine in Baltimore, MD has joined the Company's ongoing Phase I/II trial in newly diagnosed elderly patients with acute myeloid leukemia (AML).

9 Oct 2012

Innovative treatments can lead to functional improvements in patients with SCIs

A series of rehabilitation studies published in the September 2012 issue of the Archives of Physical Medicine & Rehabilitation demonstrate that innovative treatments for individuals with spinal cord injuries can lead to significant functional improvements in patients and a higher quality of life.

9 Oct 2012